Designing the correct entry strategy
Doing business in China starts with getting the facts.
What classification would the product get in China? What steps need to be taken to obtain registration, what will it cost and how long will it take? Solid regulatory guidance is important to obtain the correct classification, which will determine the time to market, the way the product may be commercialised and its potential.
What are the current products available in China? Are they from local or international companies? What are the market shares and what is driving their revenues? What can we tell about pricing? Where would your product fit in this picture and what would be the strengths and weaknesses.
EMSA Healthcare believes this preliminary work is essential in order to get expectations right, and in order to determine the best entry strategy. However, we are NOT a consultancy company. Our business model lies in finding Chinese partners and managing them to optimize the revenues.
Partner and negotiation
With our strong network in China we find the most suitable partner for your products. In our network we have both local Chinese companies as well as regional players and MNCs. We are proud to have good relationships with many companies in different medical fields, with different portfolios, and different stages of development. Key in this process is to find companies that are not only able but also eager to become your partner in China.
After a contract has been signed with a Chinese partner it is important to ensure the optimal results are being obtained. At the end of the day, it's not the deal that counts, but the actual sales. We make sure that your products get the energy, focus, effort and investment to reach their full potential.